WATERTOWN, Mass. (AP) _ Enanta Pharmaceuticals Inc. (ENTA) on Monday reported a loss of $26.3 million in its fiscal fourth quarter.

On a per-share basis, the Watertown, Massachusetts-based company said it had a loss of $1.27.

The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $1.37 per share.

The biotechnology company posted revenue of $20.3 million in the period, which missed Street forecasts. Four analysts surveyed by Zacks expected $22.5 million.

For the year, the company reported that its loss widened to $121.8 million, or $5.91 per share. Revenue was reported as $86.2 million.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ENTA at https://www.zacks.com/ap/ENTA

Copyright by Automated Insights, Inc. All rights reserved.